Workflow
Paramount infighting stalls Shari Redstone's push to settle $20B Trump suit: ‘Decision constipation'
New York Post· 2025-05-21 23:40
Core Viewpoint - Paramount, controlled by Shari Redstone, is considering a settlement in a legal dispute with President Trump over alleged deceptive editing of a "60 Minutes" interview, but internal conflicts are delaying the decision [1][3][6]. Financial Implications - Paramount is reportedly willing to spend up to $50 million to settle the $20 billion lawsuit filed by Trump, which is affecting Redstone's plans to sell Paramount and its CBS News subsidiary to Skydance for $8 billion [2][17]. - If the sale goes through, Redstone and her family could receive approximately $2 billion, a significant drop from Paramount's previous valuation of nearly $40 billion [20]. Internal Conflicts - Infighting within Paramount has led to indecision regarding the settlement, with management and board members experiencing "decision constipation" due to conflicting advice [5][11]. - There is significant internal pressure against settling, with some arguing that it would undermine press freedom and be seen as capitulating to Trump's demands [6][7][10]. Legal Context - The Trump lawsuit is viewed as a critical factor in facilitating Redstone's planned sale to Skydance, as regulatory challenges from Trump's administration are complicating the merger [17][18]. - A federal judge has refused to dismiss the case, and even a potential victory on First Amendment grounds could incur costs exceeding $50 million in legal fees [13][19]. Industry Reactions - Prominent figures, including Senator Bernie Sanders, have publicly urged Redstone not to settle, framing the lawsuit as an attack on press freedom [10]. - Settling with Trump would align Paramount with other media companies that have previously paid him to resolve legal disputes [19].
Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi
GlobeNewswire News Room· 2025-05-21 23:30
Company Overview - Vigil Neuroscience, Inc. is a clinical-stage biotechnology company focused on developing treatments for neurodegenerative diseases by restoring the function of microglia, the immune cells of the brain [11] - The company is developing VG-3927, a novel small molecule TREM2 agonist aimed at treating Alzheimer's disease [11] Acquisition Details - Sanofi has entered into a definitive merger agreement to acquire Vigil for an upfront payment of $8.00 per share in cash, with a potential additional $2.00 per share contingent value right (CVR) based on the first commercial sale of VG-3927 [2][6] - The total equity value of the transaction, including the potential CVR payment, is approximately $600 million on a fully diluted basis [2] - The acquisition is expected to close in the third quarter of 2025, subject to customary conditions including shareholder approval [8] Strategic Implications - The acquisition is expected to strengthen Sanofi's development capabilities in neurology, particularly in advancing therapies for Alzheimer's disease [5][3] - Activating TREM2 is anticipated to enhance the neuroprotective function of microglia, addressing the dysregulation seen in neurodegenerative diseases [3] - There is a critical need for more effective and safer treatment options for Alzheimer's disease, as current therapies do not stop or reverse disease progression [4] Financial Aspects - Vigil shareholders will receive a total of up to $10.00 per share, consisting of $8.00 at closing and a potential $2.00 CVR [1][2] - The equity value of the transaction represents approximately $470 million based on the upfront cash payment [6] Additional Information - Iluzanebart, Vigil's monoclonal antibody program, will not be part of the acquisition and will return to Amgen prior to the transaction closing [7] - The transaction is supported by voting and support agreements representing approximately 16% of Vigil's total common shares outstanding [7]
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer's disease to the neurology pipeline
GlobeNewswire News Room· 2025-05-21 23:15
Core Viewpoint - Sanofi has announced its acquisition of Vigil Neuroscience, enhancing its neurology pipeline with a focus on developing treatments for Alzheimer's disease, specifically through the investigational drug VG-3927 [1][5]. Company Overview - Sanofi is a global healthcare company dedicated to improving lives through innovative treatments and vaccines, emphasizing sustainability and social responsibility [10]. - Vigil Neuroscience is a clinical-stage biotechnology company focused on novel therapies for neurodegenerative diseases, particularly Alzheimer's [1][3]. Acquisition Details - Sanofi will acquire all outstanding common shares of Vigil for $8 per share, totaling an equity value of approximately $470 million on a fully diluted basis [8]. - Vigil's shareholders will also receive a contingent value right (CVR) entitling them to a deferred cash payment of $2 upon the first commercial sale of VG-3927 [8]. - The acquisition is expected to close in Q3 2025, pending customary conditions including shareholder approval and regulatory clearance [9]. Strategic Importance - The acquisition aligns with Sanofi's strategic focus on neurology and aims to leverage its expertise in immunology to address critical unmet needs in Alzheimer's treatment [2][5]. - VG-3927, an oral small molecule TREM2 agonist, is anticipated to enhance the neuroprotective function of microglia, potentially improving outcomes for Alzheimer's patients [1][3]. Market Context - Current Alzheimer's therapies do not halt or reverse disease progression, highlighting the urgent need for more effective treatment options [4]. - Sanofi's prior $40 million investment in Vigil demonstrates its proactive approach to securing innovative solutions in the healthcare sector [5].
These Top-Rated Stocks Are Surging After Earnings: GDS, GOOS
ZACKS· 2025-05-21 23:05
Group 1: GDS Holdings - GDS Holdings reported Q1 EPS of $0.48, significantly exceeding expectations of an adjusted loss of -$0.22, and improved from -$0.27 in the prior year quarter [5][7] - The company achieved a revenue growth rate of 12% and EBITDA growth of 16%, attributed to a focus on backlog, delivery, and project acceleration [5] - GDS Holdings signed a deal for 152 megawatts of capacity during Q1, indicating higher demand for AI training services [6] Group 2: Canada Goose - Canada Goose reported Q4 earnings of $0.23 per share, surpassing estimates of $0.16, and up from Q1 EPS of $0.14 in the comparative quarter [9] - The direct-to-consumer business increased by 15% year over year, driven by successful marketing campaigns, particularly in the U.S. [10] - Inventory levels for Canada Goose fell by 14%, reflecting improved operational efficiency [10]
Markets Slide on Bond Option; Q1 Earnings After the Close
ZACKS· 2025-05-21 23:01
Market Overview - Major market indexes closed lower, with the Dow down 816 points (-1.91%), S&P 500 down 95 points (-1.61%), Nasdaq down 270 points (-1.41%), and Russell 2000 down 55 points (-2.63%) [1] Bond Market Impact - A sell-off in bonds occurred due to the U.S. government's plans for a major tax cut bill, contributing to an increase in Treasury yields: 10-year yields rose to +4.59%, 2-year yields to +4.01%, and 30-year yields exceeded +5% [2] AI Industry Developments - Jony Ive's AI startup io is being acquired by OpenAI for $6.4 billion, leading to a decline in Apple’s stock price by 2.3%, indicating increased competition in AI design and implementation [3] Company Earnings Reports - Urban Outfitters (URBN) reported Q1 earnings of $1.16 per share, surpassing expectations of 81 cents, with revenues of $1.33 billion exceeding the consensus of $1.29 billion; shares rose by 9% after hours [4] - Snowflake (SNOW) reported earnings of 24 cents per share, beating expectations by 2 cents, with quarterly sales of $1.04 billion, surpassing the anticipated $1.00 billion; shares gained 7% [4] - Zoom Communications (ZM) reported earnings of $1.43 per share, exceeding the consensus of $1.30, with revenues of $1.17 billion slightly above expectations; shares initially jumped but moderated afterward [5] Upcoming Economic Reports - Anticipated economic reports include Weekly Jobless Claims, S&P flash Services and Manufacturing PMI, and Existing Home Sales, with expectations for steady jobless claims, lower PMI results, and slightly higher home sales month over month [6]
Zoom (ZM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-05-21 23:01
Core Insights - Zoom Communications reported revenue of $1.17 billion for the quarter ended April 2025, reflecting a year-over-year increase of 2.9% and a surprise of +0.89% over the Zacks Consensus Estimate of $1.16 billion [1] - The earnings per share (EPS) for the quarter was $1.43, surpassing the previous year's $1.35 and exceeding the consensus EPS estimate of $1.30 by +10.00% [1] Financial Performance Metrics - Zoom's shares have returned +15.8% over the past month, outperforming the Zacks S&P 500 composite's +12.7% change [3] - The company has 182,600 enterprise customers, which is below the average estimate of 193,166 [4] - Customers generating over $100K in trailing twelve months (TTM) revenue totaled 4,192, slightly above the average estimate of 4,155 [4] - Current Remaining Performance Obligation (RPO) stands at $2.36 billion, exceeding the average estimate of $2.33 billion [4] - Total Remaining Performance Obligations (RPO) is $3.88 billion, slightly above the average estimate of $3.86 billion [4] - Non-Current Remaining Performance Obligation (RPO) is $1.52 billion, marginally above the average estimate of $1.51 billion [4] Geographic Revenue Breakdown - Revenue from the Americas reached $848 million, surpassing the average estimate of $838.48 million, with a year-over-year change of +3.5% [4] - Revenue from Europe, the Middle East, and Africa (EMEA) was $185 million, slightly above the average estimate of $184.58 million, reflecting a +0.5% change year-over-year [4] - Revenue from the Asia Pacific (APAC) region was $142 million, just below the average estimate of $143.01 million, with a +2.9% change compared to the previous year [4] - Online revenue was reported at $470 million, slightly below the average estimate of $472.82 million [4] - Enterprise revenue reached $704.70 million, exceeding the average estimate of $689.42 million [4]
Urban Outfitters (URBN) Reports Q1 Earnings: What Key Metrics Have to Say
ZACKS· 2025-05-21 23:01
Core Insights - Urban Outfitters reported revenue of $1.33 billion for the quarter ended April 2025, reflecting a 10.7% increase year-over-year and a surprise of +3.37% over the Zacks Consensus Estimate of $1.29 billion [1] - Earnings per share (EPS) reached $1.16, significantly higher than the $0.69 reported in the same quarter last year, resulting in an EPS surprise of +43.21% compared to the consensus estimate of $0.81 [1] Financial Performance Metrics - Urban Outfitters' shares have returned +22.7% over the past month, outperforming the Zacks S&P 500 composite's +12.7% change [3] - The company has a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3] Retail Operations - The number of stores for Free People was 237, slightly above the four-analyst average estimate of 236 [4] - Urban Outfitters had 257 stores, exceeding the average estimate of 254 [4] - Anthropologie's store count matched the average estimate of 241 [4] Comparable Store Sales - Comparable store sales increased by 4.8% year-over-year, surpassing the average estimate of 3.4% [4] Net Sales by Brand - Urban Outfitters' net sales were $273.51 million, exceeding the average estimate of $259.71 million, with a year-over-year change of +1.2% [4] - Anthropologie's net sales reached $569.93 million, above the average estimate of $555.86 million, reflecting an +8.3% year-over-year change [4] - Nuuly's net sales were $124.35 million, significantly higher than the average estimate of $103.98 million, marking a +59.6% year-over-year increase [4] - Free People's net sales were $353.11 million, slightly below the average estimate of $362.51 million, with a +10.8% year-over-year change [4] Wholesale and Subscription Operations - Net sales from wholesale operations were $74.64 million, exceeding the average estimate of $70.28 million, with a +24.2% year-over-year change [4] - Subscription operations generated $124.35 million in net sales, surpassing the average estimate of $97.99 million [4]
EnerSys (ENS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2025-05-21 23:01
Core Insights - EnerSys reported revenue of $974.8 million for the quarter ended March 2025, reflecting a 7% increase year-over-year, with EPS at $2.97 compared to $2.08 in the same quarter last year [1] - The revenue fell short of the Zacks Consensus Estimate by -0.06%, while the EPS exceeded the consensus estimate by +6.83% [1] Financial Performance Metrics - Specialty Net Sales reached $177.80 million, surpassing the estimated $164.85 million, marking a +21.4% change year-over-year [4] - Motive Power Net Sales were reported at $392.30 million, slightly below the average estimate of $396.19 million, indicating a -0.6% change year-over-year [4] - Energy Systems Net Sales totaled $398.80 million, compared to the average estimate of $415.83 million, reflecting an +8% change year-over-year [4] - Operating Earnings for Energy Systems were $27 million, below the estimated $30.23 million [4] - Operating Earnings for Motive Power were $57.90 million, compared to the average estimate of $61.79 million [4] - Operating Earnings for Specialty were reported at $10.20 million, below the average estimate of $12.40 million [4] Stock Performance - EnerSys shares have returned +19.4% over the past month, outperforming the Zacks S&P 500 composite's +12.7% change [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]
Take-Two Interactive: A Closer Look at Its Market Potential
The Motley Fool· 2025-05-21 23:00
Anand Chokkavelu, CFA has no position in any of the stocks mentioned. Rick Munarriz has no position in any of the stocks mentioned. Toby Bordelon has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Take-Two Interactive Software. The Motley Fool has a disclosure policy. ...
Cracker Barrel Elects Steve Bramlage to Board of Directors
Prnewswire· 2025-05-21 23:00
Core Viewpoint - Cracker Barrel Old Country Store, Inc. has elected Steve Bramlage to its Board of Directors, enhancing its leadership with significant retail and financial expertise [1][3]. Company Overview - Cracker Barrel Old Country Store, Inc. operates 660 company-owned locations across 43 states and owns the fast-casual Maple Street Biscuit Company, focusing on providing homestyle food and unique retail products [4]. Leadership Background - Steve Bramlage, the new Board member, is currently the CFO of Casey's General Stores, overseeing financial operations and strategic planning since joining in 2020. He has prior experience as CFO at Aramark and Owens-Illinois, and has held various financial roles at PPG Industries, Eli-Lilly, and EY [2]. Board's Strategic Vision - The Chairman of Cracker Barrel's Board expressed confidence in Bramlage's ability to contribute to the company's strategic transformation and deliver value to shareholders, highlighting the importance of retail industry knowledge and executive leadership experience [3].